Hematopoietic development of vav-/- mouse embryonic stem cells.
AUTOR(ES)
Zhang, R
RESUMO
The vav protooncogene product is expressed nearly exclusively in hematopoietic lineages and contains several structural motifs (SH2/SH3 domains and a dbl-oncogene homology region) typical of proteins functioning in signaling pathways. To ascertain if vav expression is required for hematopoiesis we generated vav-negative mouse embryonic stem cells by gene targeting and examined the consequences of loss of vav function on erythroid and myeloid development in vitro and in vivo. In conflict with the conclusions drawn from expression of antisense vav RNA in embryonic stem cells [Wulf, G. M., Adra, C. N. & Lim, B. (1993) EMBO J. 12, 5065-5074], we observed erythroid and myeloid development in the absence of vav. These experiments demonstrate that vav expression is not absolutely required for hematopoietic development.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=45518Documentos Relacionados
- Inhibition of hematopoietic development from embryonic stem cells by antisense vav RNA.
- Recycling selectable markers in mouse embryonic stem cells.
- Resting and activated subsets of mouse multipotent hematopoietic stem cells.
- Inducible site-directed recombination in mouse embryonic stem cells.
- Cotransformation and gene targeting in mouse embryonic stem cells.
